Guaren, Marris Jane P.
HRN: 13-96-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/18/2025
06/28/2025
PO
13 Ml
Q 8 Hours
Intestinal Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes